SANO trial: innovations, risks, and unanswered questions - Authors' reply.

van der Wilk BJ, Eyck BM, Lagarde SM, Wijnhoven BPL, van Lanschot JJB, SANO Study Group

Open source

DOI
10.1016/s1470-2045(25)00356-0
Published
2025 Jul
Container
The Lancet. Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-25-00356-0,
  title = {SANO trial: innovations, risks, and unanswered questions - Authors' reply.},
  author = {van der Wilk BJ and Eyck BM and Lagarde SM and Wijnhoven BPL and van Lanschot JJB and SANO Study Group},
  year = {2025},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(25)00356-0},
  url = {https://doi.org/10.1016/s1470-2045(25)00356-0}
}

RIS

TY  - JOUR
TI  - SANO trial: innovations, risks, and unanswered questions - Authors' reply.
AU  - van der Wilk BJ
AU  - Eyck BM
AU  - Lagarde SM
AU  - Wijnhoven BPL
AU  - van Lanschot JJB
AU  - SANO Study Group
PY  - 2025
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(25)00356-0
UR  - https://doi.org/10.1016/s1470-2045(25)00356-0
ER  - 

APA

BJ, V. D. W., BM, E., SM, L., BPL, W., JJB, V. L., & Group, S. S. (2025). SANO trial: innovations, risks, and unanswered questions - Authors' reply.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(25)00356-0

Source records